This review begins with a historical accounting of the evolution of the concept of mild cognitive dysfunction, including nomenclature and criteria from Kral to Petersen. A critical analysis of the main elements relating to assessment and diagnosis of mild cognitive dysfunction is provided. Methodological limitations in design, measurement, and characterization, especially as they relate to older African Americans, are identified. Data from a 15-year longitudinal study of community-dwelling African Americans in Indianapolis, Indiana, indicate a 23% prevalence of all-cause mild cognitive dysfunction, with approximately 25% progressing to dementia in 2 years and another 25% reverting to normal cognition in the same interval. Factors contributing to this longitudinal variability in outcomes are reviewed, including the role of medical health factors. The review closes with suggestions for next steps in the epidemiological research of mild cognitive impairment. (J Geriatr Psychiatry Neurol 2007;20:215—226)
DeKosky ST, Marek K.Looking backward to move forward: early detection of neurodegenerative disorders . Science. 2003; 302:830-834.
2.
Riley KP, Snowdon DA, Markesbery WRAlzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol.2002 ;51:567-577.
3.
Callahan CM, Hendrie HC, Tierney WMDocumentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med.1995;122:422-429.
4.
Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry.1995;152:1485-1492.
5.
Hendrie HC, Ogunniyi A., Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA.2001;285:739-747.
6.
Unverzagt FW , Gao S., Baiyewu O., et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology . 2001;57:1655-1662.
7.
Kral VASenescent forgetfulness: benign and malignant. CMAJ. 1962;86:257-260.
8.
Hughes CP, Berg L., Danziger WL, Coben LA, Martin RLA new scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-572.
9.
Morris JCThe Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
10.
Morris JC, McKeel DW, Storandt M., et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology. 1991;41:469-478.
11.
Morris JC, Storandt M., Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease . Arch Neurol.2001;58:397-405.
12.
Rubin EH, Morris JC, Grant EA, Vendegna T.Very mild senile dementia of the Alzheimer's type, I: clinical assessment . Arch Neurol.1989;46:379-382.
13.
Crook T., Bartus RT, Ferris SH, Whitehouse P., Cohen GD, Gershon S.Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health work group . Dev Neuropsychol. 1986;2:261-276.
14.
Ivnik RJ, Malec JF, Tangalos EG, Petersen RC, Kokmen E., Kurland LT Mayo's Older Americans Normative Studies: WMS-R norms for ages 56 to 94. Clin Neuropsychol. 1992;6: 49-82.
15.
Ivnik RJ, Malec JF, Tangalos EG, Petersen RC, Kokmen E., Kurland LT Mayo's Older Americans Normative Studies: updated AVLT norms for ages 56 to 97. Clin Neuropsychol. 1992;6:83-104.
16.
Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RCNeuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol. 1996;10:262-278.
17.
Ivnik RJ, Malec JF, Tangalos EG, Petersen RC, Kokmen E., Kurland LTThe Auditory-Verbal Learning Test (AVLT): norms for ages 55 years and older . Psychol Assess.1990;2:304-312.
18.
Ivnik RJ, Malec JF, Smith GE, et al. Mayo's Older Americans Normative Studies: WAIS-R norms for ages 56 to 97. Clin Neuropsychol. 1992;6(suppl):1-30.
Wechsler D.WAIS-III Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 1997 .
21.
Levy R.; Working Party of the International Psychogeriatric Association in Collaboration With the World Health Organization. Aging-associated cognitive decline [published correction appears in Int Psychogeriatr. 1994;6:133] . Int Psychogeriatr. 1994;6:63-68.
22.
Petersen RC , Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA.1995;273: 1274-1278.
Smith GE, Petersen RC, Parisi JE, et al. Definition, course, and outcome of mild cognitive impairment . Aging Neuropsychol Cogn. 1996;3:131-147.
25.
Ritchie K., Artero S., Touchon J.Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 2001;56:37-42.
26.
Fisk JD, Merry HR, Rockwood K.Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 2003;61:1179-1184.
27.
Petersen R.Mild cognitive impairment as a diagnostic entity . J Intern Med.2004;256:183-194.
28.
Petersen RC , Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol.2001;58:1985-1992.
29.
Graham JE, Rockwood K., Beattie LB, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796.
30.
Ebly EM, Hogan DB, Parhad IMCognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol.1995 ;52:612-619.
31.
Baiyewu O., Unverzagt FW, Ogunniyi A., et al. Cognitive impairment in community-dwelling older Nigerians: clinical correlates and stability of diagnosis. Eur J Neurol.2002; 9:573-580.
32.
Backman L., Jones S., Berger AK, Laukka EJ, Small BJCognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology. 2005;19:520-531.
33.
O'Connor DW, Pollitt PA, Roth M., Brook PB, Reiss BBMemory complaints and impairment in normal, depressed, and demented elderly persons identified in a community survey. Arch Gen Psychiatry.1990;47:224-227.
34.
Saykin AJ, Wishart HA, Rabin LA, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006;67:834-842.
35.
Schmand B., Jonker C., Geerlings MI, Lindeboom J.Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry. 1997;171:373-376.
36.
Schofield PW , Jacobs D., Marder K., Sano M., Stern Y.The validity of new memory complaints in the elderly. Arch Neurol.1997;54:756-759.
37.
Kemp NM, Brodaty H., Pond D., Luscombe G.Diagnosing dementia in primary care: the accuracy of informant reports. Alzheimer Dis Assoc Disord. 2002;16:171-176.
38.
Tabert MH, Albert SM, Borukhova-Milov L., et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758-764.
39.
Tuokko H., Frerichs R., Graham J., et al. Five-year follow-up of cognitive impairment with no dementia . Arch Neurol.2003; 60:577-582.
40.
Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons . Neurology. 2002;59:198-205.
41.
Ganguli M., Dodge HH, Shen C., DeKosky STMild cognitive impairment, amnestic type: an epidemiologic study. Neurology.2004;63:115-121.
42.
Manly JJ, Jacobs DM, Sano M., et al. Cognitive test performance among nondemented elderly African Americans and whites. Neurology. 1998;50:1238-1245.
43.
Unverzagt FW , Hall KS, Torke AM, et al. Effects of age, education, and gender on CERAD neuropsychological test performance in an African American sample . Clin Neuropsychol. 1996;10:180-190.
44.
Marcopulos BA, McLain CA, Giuliano AJCognitive impairment or inadequate norms? A study of healthy, rural, older adults with limited education. Clin Neuropsychol.1997;11: 111-131.
45.
Fillenbaum G., Heyman A., Williams K., Prosnitz B., Burchett B.Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol.1990 ;43:651-660.
46.
Murden RA, McRae TD, Kaner S., Bucknam MEMini-Mental State Exam scores vary with education in blacks and whites. J Am Geriatr Soc.1991;39:149-155.
47.
Brown LM, Schinka JA, Mortimer JA, Graves AB3MS normative data for elderly African Americans. J Clin Exp Neuropsychol.2003;25:234-241.
48.
Fillenbaum GG, Heyman A., Huber MS, Ganguli M., Unverzagt FWPerformance of elderly African American and white community residents on the CERAD Neuropsychological Battery. J Int Neuropsychol Soc.2001;7:502-509.
49.
Lucas JA, Ivnik RJ, Smith GE, et al. A brief report on WAIS-R normative data collection in Mayo's Older African Americans Normative Studies. Clin Neuropsychol . 2005;19:184-188.
50.
Lucas JA, Ivnik RJ, Smith GE, et al. Mayo's Older African Americans Normative Studies: WMS-R norms for African American elders. Clin Neuropsychol. 2005;19:189-213.
51.
Lucas JA, Ivnik RJ, Smith GE, et al. Mayo's Older African Americans Normative Studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token Test, WRAT-3 Reading, Trail Making Test, Stroop Test, and Judgment of Line Orientation. Clin Neuropsychol . 2005;19:243-269.
52.
Ferman TJ, Lucas JA, Ivnik RJ, et al. Mayo's Older African Americans Normative Studies: Auditory Verbal Learning Test norms for African American elders. Clin Neuropsychol . 2005;19:214-228.
53.
Ross TP, Lichtenberg PAExpanded normative data for the Boston Naming Test for use with urban, elderly medical patients. Clin Neuropsychol. 1998;12:475-481.
54.
Marcopulos BA, Mclain CAAre our norms “normal”? A 4-year follow-up study of a biracial sample of rural elders with low education. Clin Neuropsychol. 2003;17:19-33.
55.
Friedman MA , Schinka JA, Mortimer JA, Graves ABHopkins Verbal Learning Test—Revised: Norms for elderly African Americans. Clin Neuropsychol.2002;16:356-372.
56.
Johnson AS, Flicker LJ, Lichtenberg PAReading ability mediates the relationship between education and executive function tasks. J Int Neuropsychol Soc.2006 ;12:64-71.
57.
Manly JJ, Byrd DA, Touradji P., Stern Y.Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol.2004;11:37-46.
58.
Manly JJ, Jacobs DM, Touradji P., Small SA, Stern Y.Reading level attenuates differences in neuropsychological test performance between African American and white elders. J Int Neuropsychol Soc.2002;8:341-348.
59.
Byrd DA, Sanchez D., Manly JJNeuropsychological test performance among Caribbean-born and US-born African American elderly: the role of age, education and reading level. J Clin Exp Neuropsychol. 2005;27:1056-1069.
60.
Manly JJ, Jacobs DM, Sano M., et al. Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. J Int Neuropsychol Soc. 1999;5:191-202.
61.
Baiyewu O., Unverzagt FW, Lane KA, et al. The Stick Design test: a new measure of visuoconstructional ability. J Int Neuropsychol Soc. 2005;11:598-605.
62.
DiCarlo A., Baldereschi M., Amaducci L., et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability: the Italian Longitudinal Study on Aging. J Am Geriatr Soc.2000;48:775-782.
63.
Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol.2003;60: 1385-1389.
64.
Prencipe M. , Santini M., Casini AR, Pezzella FR, Scaldaferri N., Culasso F.Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population . J Neurol.2003;250:907-912.
65.
Busse A., Bischkopf J., Riedel-Heller SG, Angermeyer MCMild cognitive impairment: prevalence and incidence according to different diagnostic criteria: results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry.2003;182:449-454.
66.
Hanninen T. , Hallikainen M., Tuomainen S., Vanhanen M., Soininen H.Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand.2002;106:148-154.
67.
Boeve B., McCormick J., Smith G., et al. Mild cognitive impairment in the oldest old. Neurology. 2003;60:477-480.
68.
Ikeda M., Shigenobu K.The prevalence of mild cognitive impairment (MCI) among the community-dwelling elderly: findings from the 2nd Nakayama study [in Japanese]. Seishin Shinkeigaku Zasshi. 2003;105:381-386.
69.
Pfeffer RI, Afifi AA, Chance JMPrevalence of Alzheimer's disease in a retirement community. Am J Epidemiol.1987;125: 420-436.
70.
Prencipe M., Casini AR, Ferretti C., Lattanzio MT, Fiorelli M., Culasso F.Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry. 1996;60:628-633.
71.
Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ. 1994;150:899-913.
72.
Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol.2005;62:1739-1746.
73.
O'Connor DW, Pollitt PA, Hyde JB, Fellowes JL, Miller ND, Roth M.A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand.1990;81:78-82.
74.
Larrieu S., Letenneur L., Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594-1599.
75.
Busse A., Bischkopf J., Riedel-Heller SG, Angermeyer MC; LeipzigLongitudinal Study of the Aged LEILA75+. Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand.2003;108:71-81.
76.
Elias MF, Wolf PA, D'Agostino RB, Cobb J., White LRUntreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol.1993 ;138: 353-364.
77.
Launer LJ, Masaki K., Petrovitch H., Foley D., Havlik RJThe association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA.1995;274:1846-1851.
78.
Guo Z., Fratiglioni L., Winblad B., Viitanen M.Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungsholmen Project . Am J Epidemiol.1997;145:1106-1113.
79.
Pandav R., Dodge HH, DeKosky ST, Ganguli M.Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study. Arch Neurol.2003;60: 1123-1128.
80.
Hebert LE, Scherr PA, Bennett DA, et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004;62:2021-2024.
81.
Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RBLower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord.2003;27:260-268.
82.
Murray M., Lane K., Gao S., et al. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med.2002;162:2090-2096.
Gregg EW, Yaffe K., Cauley JA, et al. Study of Osteoporotic Fractures Research Group. Is diabetes associated with cognitive impairment and cognitive decline among older women?Arch Intern Med.2000;160:174-180.
85.
Grodstein F. , Chen J., Wilson R., Manson J.Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care.2001;24:1060-1065.
86.
Logroscino G., Kang J., Grodstein F.Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ.2004 ;328:548-553.
87.
Yaffe K., Barrett-Connor E., Lin F., Grady D.Serum lipoprotein levels, statin use, and cognitive function in older women . Arch Neurol.2002;59:378-384.
88.
Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RSDietary fat intake and 6-year cognitive change in an older biracial community population. Neurology. 2004;62:1573-1579.
89.
Li G., Shofer J., Kukull W., et al. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology. 2005;65:1045-1050.
90.
Basu R., Dodge H., Stoehr GP, Ganguli M.Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Am J Geriatr Psychiatry. 2003;11:205-213.
91.
Mulsant BH, Pollock BG, Kirshner M., Shen C., Dodge H., Ganguli M.Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry . 2003;60:198-203.
92.
Bozoki A., Giordani B., Heidebrink JL, Berent S., Foster NLMild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol.2001;58:411-416.
93.
Tabert MH, Manly JJ, Liu XH, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry . 2006;63:916-924.
